STOCKHOLDERS' EQUITY (Tables)

9 Months Ended

Nov. 30, 2019

Equity [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive income (loss) (in thousands):

	Three Months Ended				Nine Months Ended
	November 30,				November 30,
	2019		2018		2019		2018
Cost of revenues	$	221	$	251	$	558	$	640
Research and development		723		538		1,769		1,323
Selling and marketing		1,058		808		2,709		2,059
General and administrative		1,650		1,344		4,342		4,066
	$	3,652	$	2,941	$	9,378	$	8,088

Summary of Stock Option Activity

Changes in our outstanding stock options during the nine months ended November 30, 2019 were as follows (options in thousands):

	Number of Options			Weighted Average Exercise Price		Weighted average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at February 28, 2019		1,054		$	13.44		5.8
Granted		171			11.11
Exercised		(106	)		2.35
Forfeited or expired		—			—
Outstanding at November 30, 2019		1,119		$	14.14		6.2	$	1,380
Exercisable at November 30, 2019		681		$	12.46		4.7	$	1,380

Summary of Restricted Stock Shares (RSU's), and Performance Stock Units (PSU's) Activity

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the nine months ended November 30, 2019 were as follows (restricted shares, PSUs and RSUs in thousands):

	Number of Restricted Shares, PSUs and RSUs			Weighted Average Grant Date Fair Value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Outstanding at February 28, 2019		1,507		$	19.77
Granted		1,561			11.30
Vested		(467	)		18.91		159
Forfeited		(229	)		17.30
Outstanding at November 30, 2019		2,372		$	14.58